Renal and systemic hemodynamics in black and white hypertensive patients

被引:6
|
作者
Rockstroh, JK
Schmieder, RE
Schlaich, MP
Messerli, FH
机构
[1] UNIV ERLANGEN NURNBERG, MED KLIN 4, DEPT MED 4, D-90471 NURNBERG, GERMANY
[2] UNIV BONN, DEPT MED, D-5300 BONN, GERMANY
[3] ALTON OCHSNER MED FDN & OCHSNER CLIN, DEPT INTERNAL MED, HYPERTENS DIS SECT, NEW ORLEANS, LA 70121 USA
关键词
essential hypertension; race; target organ damage; vascular resistance; cardiac structure;
D O I
10.1016/S0895-7061(97)00165-9
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Greater mortality and morbidity for cardiovascular events and renal complications have been reported in black than in white hypertensive patients. In this study we examined whether race per se affected markers of early target organ damage in a population of black and white hypertensive patients in whom casual as well as ambulatory blood pressure measurements were obtained. We assessed renal and systemic hemodynamics by measuring mean arterial pressure invasively, renal blood flow by I-131-para-aminohippuric acid clearance, and cardiac output by the indocyanine dye dilution technique. Left ventricular structure was determined by two-dimensional guided M-mode echocardiography. No significant differences in cardiac output, total peripheral resistance, renal blood now, and renal racial populations. Indices of myocardial structure were also comparable between black and white hypertensive patients. This was true regardless whether all patients were analyzed, or male patients only, or only those with elevated ambulatory blood pressure measurements. When defining arterial pressure by 24-h ambulatory monitoring, no differences in early target organ damage can be found between black and white patients with mild essential hypertension. (C) 1997 American Journal of Hypertension, Ltd.
引用
收藏
页码:971 / 978
页数:8
相关论文
共 50 条
  • [31] Intrarenal hemodynamics and blood pressure in hypertensive patients with renal artery anomalies
    Savelyeva, NY
    Gapon, LI
    Zherzhova, AY
    Vdovenko, SV
    TERAPEVTICHESKII ARKHIV, 2005, 77 (09) : 20 - 23
  • [32] EFFECT OF SPLANCHNIC BLOCK ON RENAL HEMODYNAMICS AND RENIN PRODUCTION IN HYPERTENSIVE PATIENTS
    MORLIN, C
    LORELIUS, LE
    LOFROTH, PO
    WIDE, L
    WIKLUND, L
    ABERG, H
    ACTA MEDICA SCANDINAVICA, 1979, : 122 - 126
  • [33] Angiotensinogen genotype predicts abnormal renal hemodynamics in young hypertensive patients
    Patel, Tejas V.
    Williams, Gordon H.
    Fisher, Naomi Deirdre L.
    JOURNAL OF HYPERTENSION, 2008, 26 (07) : 1353 - 1359
  • [34] COMPARISON OF THE SYSTEMIC HEMODYNAMICS IN NORMOTENSIVE AND HYPERTENSIVE RATS
    ISMAILOV, SI
    MEDVEDEV, OS
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1982, 93 (05) : 584 - 586
  • [35] EFFECT OF CORINFAR OF THE SYSTEMIC HEMODYNAMICS AND CONTRACTILE FUNCTION OF THE MYOCARDIUM IN PATIENTS WITH HYPERTENSIVE DISEASE
    TOKARENKO, II
    VRACHEBNOE DELO, 1990, (07): : 21 - 23
  • [36] EFFECTS OF LABETALOL ON SYSTEMIC AND PULMONARY HEMODYNAMICS AT REST AND DURING EXERCISE IN HYPERTENSIVE PATIENTS
    FAGARD, R
    AMERY, A
    REYBROUCK, T
    LIJNEN, P
    BILLIET, L
    CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1978, 55 : S279 - S281
  • [37] NITRIC-OXIDE SYNTHASE INHIBITION IN SPONTANEOUSLY HYPERTENSIVE RATS - SYSTEMIC, RENAL, AND GLOMERULAR HEMODYNAMICS
    ONO, H
    ONO, Y
    FROHLICH, ED
    HYPERTENSION, 1995, 26 (02) : 249 - 255
  • [38] Efficacy of captopril and nifedipine in black and white patients with hypertensive crisis
    Damasceno, A
    Ferreira, B
    Patel, S
    Sevene, E
    Polonia, J
    JOURNAL OF HUMAN HYPERTENSION, 1997, 11 (08) : 471 - 476
  • [39] Efficacy of captopril and nifedipine in black and white patients with hypertensive crisis
    A Damasceno
    B Ferreira
    S Patel
    E Sevene
    J Polónia
    Journal of Human Hypertension, 1997, 11 : 471 - 476
  • [40] EFFECT OF DOXAZOSIN ON BLOOD-PRESSURE AND RENAL HEMODYNAMICS OF HYPERTENSIVE PATIENTS WITH RENAL-FAILURE
    BAILEY, RR
    NAIRN, PL
    WALKER, RJ
    NEW ZEALAND MEDICAL JOURNAL, 1986, 99 (815) : 942 - 945